Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening

ABSTRACT Cryptococcus neoformans is a pathogenic fungus that is responsible for up to half a million cases of meningitis globally, especially in immunocompromised individuals. Common fungistatic drugs, such as fluconazole, are less toxic for patients but have low efficacy for initial therapy of the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yoon-Dong Park, Wei Sun, Antonio Salas, Avan Antia, Cindy Carvajal, Amy Wang, Xin Xu, Zhaojin Meng, Ming Zhou, Gregory J. Tawa, Jean Dehdashti, Wei Zheng, Christina M. Henderson, Adrian M. Zelazny, Peter R. Williamson
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://doaj.org/article/db380ece62464859a07b18fca038063f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:db380ece62464859a07b18fca038063f
record_format dspace
spelling oai:doaj.org-article:db380ece62464859a07b18fca038063f2021-11-15T15:50:18ZIdentification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening10.1128/mBio.01073-162150-7511https://doaj.org/article/db380ece62464859a07b18fca038063f2016-09-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01073-16https://doaj.org/toc/2150-7511ABSTRACT Cryptococcus neoformans is a pathogenic fungus that is responsible for up to half a million cases of meningitis globally, especially in immunocompromised individuals. Common fungistatic drugs, such as fluconazole, are less toxic for patients but have low efficacy for initial therapy of the disease. Effective therapy against the disease is provided by the fungicidal drug amphotericin B; however, due to its high toxicity and the difficulty in administering its intravenous formulation, it is imperative to find new therapies targeting the fungus. The antiparasitic drug bithionol has been recently identified as having potent fungicidal activity. In this study, we used a combined gene dosing and drug affinity responsive target stability (GD-DARTS) screen as well as protein modeling to identify a common drug binding site of bithionol within multiple NAD-dependent dehydrogenase drug targets. This combination genetic and proteomic method thus provides a powerful method for identifying novel fungicidal drug targets for further development. IMPORTANCE Cryptococcosis is a neglected fungal meningitis that causes approximately half a million deaths annually. The most effective antifungal agent, amphotericin B, was developed in the 1950s, and no effective medicine has been developed for this disease since that time. A key aspect of amphotericin B’s effectiveness is thought to be because of its ability to kill the fungus (fungicidal activity), rather than just stop or slow its growth. The present study utilized a recently identified fungicidal agent, bithionol, to identify potential fungicidal drug targets that can be used in developing modern fungicidal agents. A combined protein and genetic analysis approach was used to identify a class of enzymes, dehydrogenases, that the fungus uses to maintain homeostasis with regard to sugar nutrients. Similarities in the drug target site were found that resulted in simultaneous inhibition and killing of the fungus by bithionol. These studies thus identify a common, multitarget site for antifungal development.Yoon-Dong ParkWei SunAntonio SalasAvan AntiaCindy CarvajalAmy WangXin XuZhaojin MengMing ZhouGregory J. TawaJean DehdashtiWei ZhengChristina M. HendersonAdrian M. ZelaznyPeter R. WilliamsonAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 7, Iss 4 (2016)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Yoon-Dong Park
Wei Sun
Antonio Salas
Avan Antia
Cindy Carvajal
Amy Wang
Xin Xu
Zhaojin Meng
Ming Zhou
Gregory J. Tawa
Jean Dehdashti
Wei Zheng
Christina M. Henderson
Adrian M. Zelazny
Peter R. Williamson
Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening
description ABSTRACT Cryptococcus neoformans is a pathogenic fungus that is responsible for up to half a million cases of meningitis globally, especially in immunocompromised individuals. Common fungistatic drugs, such as fluconazole, are less toxic for patients but have low efficacy for initial therapy of the disease. Effective therapy against the disease is provided by the fungicidal drug amphotericin B; however, due to its high toxicity and the difficulty in administering its intravenous formulation, it is imperative to find new therapies targeting the fungus. The antiparasitic drug bithionol has been recently identified as having potent fungicidal activity. In this study, we used a combined gene dosing and drug affinity responsive target stability (GD-DARTS) screen as well as protein modeling to identify a common drug binding site of bithionol within multiple NAD-dependent dehydrogenase drug targets. This combination genetic and proteomic method thus provides a powerful method for identifying novel fungicidal drug targets for further development. IMPORTANCE Cryptococcosis is a neglected fungal meningitis that causes approximately half a million deaths annually. The most effective antifungal agent, amphotericin B, was developed in the 1950s, and no effective medicine has been developed for this disease since that time. A key aspect of amphotericin B’s effectiveness is thought to be because of its ability to kill the fungus (fungicidal activity), rather than just stop or slow its growth. The present study utilized a recently identified fungicidal agent, bithionol, to identify potential fungicidal drug targets that can be used in developing modern fungicidal agents. A combined protein and genetic analysis approach was used to identify a class of enzymes, dehydrogenases, that the fungus uses to maintain homeostasis with regard to sugar nutrients. Similarities in the drug target site were found that resulted in simultaneous inhibition and killing of the fungus by bithionol. These studies thus identify a common, multitarget site for antifungal development.
format article
author Yoon-Dong Park
Wei Sun
Antonio Salas
Avan Antia
Cindy Carvajal
Amy Wang
Xin Xu
Zhaojin Meng
Ming Zhou
Gregory J. Tawa
Jean Dehdashti
Wei Zheng
Christina M. Henderson
Adrian M. Zelazny
Peter R. Williamson
author_facet Yoon-Dong Park
Wei Sun
Antonio Salas
Avan Antia
Cindy Carvajal
Amy Wang
Xin Xu
Zhaojin Meng
Ming Zhou
Gregory J. Tawa
Jean Dehdashti
Wei Zheng
Christina M. Henderson
Adrian M. Zelazny
Peter R. Williamson
author_sort Yoon-Dong Park
title Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening
title_short Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening
title_full Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening
title_fullStr Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening
title_full_unstemmed Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening
title_sort identification of multiple cryptococcal fungicidal drug targets by combined gene dosing and drug affinity responsive target stability screening
publisher American Society for Microbiology
publishDate 2016
url https://doaj.org/article/db380ece62464859a07b18fca038063f
work_keys_str_mv AT yoondongpark identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT weisun identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT antoniosalas identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT avanantia identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT cindycarvajal identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT amywang identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT xinxu identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT zhaojinmeng identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT mingzhou identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT gregoryjtawa identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT jeandehdashti identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT weizheng identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT christinamhenderson identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT adrianmzelazny identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
AT peterrwilliamson identificationofmultiplecryptococcalfungicidaldrugtargetsbycombinedgenedosinganddrugaffinityresponsivetargetstabilityscreening
_version_ 1718427429418041344